Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Oct 16;80(20):10076-85.
doi: 10.1021/acs.joc.5b01703. Epub 2015 Sep 24.

Synthesis of Naamidine A and Selective Access to N(2)-Acyl-2-aminoimidazole Analogues

Affiliations

Synthesis of Naamidine A and Selective Access to N(2)-Acyl-2-aminoimidazole Analogues

Joseph B Gibbons et al. J Org Chem. .

Abstract

A short and scalable synthesis of naamidine A, a marine alkaloid with a selective ability to inhibit epidermal growth factor receptor (EGFR)-dependent cellular proliferation, has been achieved. A key achievement in this synthesis was the development of a regioselective hydroamination of a monoprotected propargylguanidine to deliver N(3)-protected cyclic ene-guanidines. This permits the extension of this methodology to prepare N(2)-acyl analogues in a fashion that obviates the troublesome acylation of the free 2-aminoimidazoles, which typically yields mixtures of N(2)- and N(2),N(2)-diacylated products.

PubMed Disclaimer

Conflict of interest statement

Notes The authors declare no competing financial interest.

Figures

Figure 1
Figure 1
Representative Leucetta alkaloids.
Figure 2
Figure 2
X-ray structures of 18b and 20h.
Figure 3
Figure 3
Antiproliferative effects of naamidine A and 20h.
Scheme 1
Scheme 1
First Generation Synthesis of Naamidine A and Analogues
Scheme 2
Scheme 2
Synthesis of Naamidine A (6)
Scheme 3
Scheme 3
Generation of N2-Acyl Naamidine A Analogues
Scheme 4
Scheme 4
Generation of N2-Acyl-2-aminoimidazoles

References

    1. Sullivan JD, Giles RL, Looper RE. Curr Bioact Compd. 2009;5:39–78.
    2. Koswatta PB, Lovely CJ. Nat Prod Rep. 2011;28:511–528. - PubMed
    3. Roué M, Quévrain E, Domart-Coulon, Bourguet-Kondracki M-L. Nat Prod Rep. 2012;29:739–751. - PubMed
    1. Dunbar DC, Rimoldi JM, Clark AM, Kelly M, Hamann MT. Tetrahedron. 2000;56:8795–8798.
    1. Crews P, Clark DP, Tenney K. J Nat Prod. 2003;66(2):177–182. - PubMed
    1. Gibbons JB, Gligorich KM, Welm BE, Looper RE. Org Lett. 2012;14:4734–4737. - PMC - PubMed
    1. Das J, Bhan A, Mandal SS, Lovely CJ. Bioorg Med Chem Lett. 2013;23:6183–6187. - PMC - PubMed

Publication types